Please login to the form below

07 Good Pharma

Better for patients, better for business

Pharma is a dirty word to some. Even to those with milder views, it’s an industry often painted with an unenviable public image. Negative portrayals of massive conglomerates that happily trade patient wellbeing for profits are too frequently projected upon the pharmaceutical sector from those outside of it. Indisputably, pharma companies are powered by profit, but so is any business. Revenue pays salaries and overheads. It’s the lifeblood of any company, big or small. Why then, does pharma get such a bad rep?

Because it matters. Because we are an ageing population terrified by the concept of growing old. Because we are more aware of our lifestyle choices, more informed about serious illness and more concerned about what it means to us. Healthcare is vital to protecting that most sacred of human commodities; our lives. It’s a big responsibility and so it’s perhaps natural that, as a wider society, we’re critical of those charged with looking after us.

So who should run pharma - shareholders or stakeholders? Both. At Havas Lynx we are passionate about improving patients’ lives and we know that the pharmaceutical companies we work with share this commitment. We believe that the key to long-term success is finding a balance between making money and making a difference. By combining moral and commercial drivers, companies can breed a long-term financial security that allows continued investment in life-changing innovations.

3rd January 2014



Company Details

Havas Lynx Group

+44 (0)161 228 7756

Contact Website

52 Princess Street
M1 6JX

Latest content on this profile

THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
The campaign encourages people who use drugs to do something remarkable – save a life
Havas Lynx Group
Andi Goes – the children’s book that helps detect early signs of dyslexia
Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst teaching from home.
Havas Lynx Group
Neurofibromatosis: a condition that’s hard to say, but even harder to live with
The Childhood Tumour Trust and Havas Lynx Group have launched a campaign to raise awareness and funds for people living with a rare genetic condition, neurofibromatosis 1 (NF1).
Havas Lynx Group
Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond
Havas Health & You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution of health and wellness.
Havas Lynx Group
Media Means Business
Creating meaningful media experiences in pharma
Havas Lynx Group
Havas Lynx Group elevates Jon Chapman and Paul Kinsella to CCOs
Havas Lynx Group announces the promotion of Jon Chapman and Paul Kinsella from Executive Creative Directors (ECD) to Chief Creative Officers (CCO) for Havas Lynx Group.
Havas Lynx Group